La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Rhinebeck Bancorp Bilan de santé

Santé financière contrôle des critères 6/6

Rhinebeck Bancorp possède un actif total de $1.3B et un capital total de $116.2M. Le total des dépôts est $1.0B et le total des prêts est $982.1M. Elle génère une marge d'intérêt nette de 3.1%. La société dispose d'une provision suffisante pour les créances douteuses, qui s'élève actuellement à 0.4% du total des prêts. Les liquidités et les placements à court terme s'élèvent à $40.9M.

Informations clés

11x

Ratio actifs/fonds propres

3.1%

Marge d'intérêt nette

Total des dépôts	US$1.03b
Ratio prêts/dépôts	Approprié
Prêts irrécouvrables	0.4%
Provision pour créances douteuses	Suffisante
Ratio de liquidité générale	Faible
Trésorerie et équivalents	US$40.88m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Could The Rhinebeck Bancorp, Inc. (NASDAQ:RBKB) Ownership Structure Tell Us Something Useful?

Jan 14

Would Shareholders Who Purchased Rhinebeck Bancorp's (NASDAQ:RBKB) Stock Year Be Happy With The Share price Today?

Nov 25

Rhinebeck Bancorp reports Q3 results

Oct 29

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Niveau d'actif: Le ratio actifs/capitaux propres de RBKB ( 11 x) est modéré.

Provision pour créances douteuses: RBKB dispose d'une provision pour créances douteuses suffisante ( 181 %).

Passifs à faible risque: 89% du passif de RBKB est constitué principalement de sources de financement à faible risque.

Niveau de prêt: RBKB a un niveau approprié de ratio prêts/actifs ( 77% ).

Dépôts à faible risque: Le ratio prêts/dépôts de RBKB ( 95% ) est approprié.

Niveau des créances douteuses: RBKB a un niveau approprié de créances douteuses ( 0.4 %).

Rhinebeck Bancorp Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Second quarter 2024 earnings released: EPS: US$0.091 (vs US$0.13 in 2Q 2023)

Rhinebeck Bancorp, Inc. Announces Chief Financial Officer Changes

First quarter 2024 earnings released: EPS: US$0.10 (vs US$0.073 in 1Q 2023)

Rhinebeck Bancorp, Inc., Annual General Meeting, May 21, 2024

Full year 2023 earnings released: EPS: US$0.41 (vs US$0.65 in FY 2022)

Now 20% undervalued

Now 20% undervalued

Now 20% undervalued

Rhinebeck Bancorp, Inc. Announces Retirement of Michael J. McDermott as Chief Financial Officer, Effective May 31, 2024

Full year 2023 earnings released: EPS: US$0.41 (vs US$0.65 in FY 2022)

Now 21% undervalued

Now 20% undervalued

Investor sentiment improves as stock rises 20%

Rhinebeck Bancorp, Inc. Announces Promotion of Mark Malone to Chief Retail Officer

Third quarter 2023 earnings released: EPS: US$0.12 (vs US$0.19 in 3Q 2022)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: EPS: US$0.13 (vs US$0.19 in 2Q 2022)

Now 22% undervalued after recent price drop

Now 24% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$0.65 (vs US$1.07 in FY 2021)

Rhinebeck Bancorp, Inc. Reports Net Charge-Offs for the Fourth Quarter Ended December 31, 2022

Full year 2022 earnings released: EPS: US$0.65 (vs US$1.07 in FY 2021)

Third quarter 2022 earnings released: EPS: US$0.19 (vs US$0.25 in 3Q 2021)

Rhinebeck Bancorp, Inc. Announces Net Charge Off for the Third Quarter Ended September 30, 2022

Rhinebeck Bancorp announces share repurchase program

Second quarter 2022 earnings released: EPS: US$0.19 (vs US$0.24 in 2Q 2021)

Rhinebeck Bancorp GAAP EPS of $0.18, revenue of $12.02M

First quarter 2022 earnings released: EPS: US$0.19 (vs US$0.31 in 1Q 2021)

Insufficient new directors

Rhinebeck Bancorp, Inc., Annual General Meeting, May 24, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS US$0.25 (vs US$0.11 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.24 (vs US$0.13 in 2Q 2020)

With EPS Growth And More, Rhinebeck Bancorp (NASDAQ:RBKB) Is Interesting

First quarter 2021 earnings released: EPS US$0.31 (vs US$0.10 in 1Q 2020)

Rhinebeck Bancorp, Inc. Announces Net Charge-Offs for the Quarter Ended March 31, 2021

Full year 2020 earnings released: EPS US$0.55 (vs US$0.56 in FY 2019)

New 90-day high: US$9.93

Have Insiders Been Buying Rhinebeck Bancorp, Inc. (NASDAQ:RBKB) Shares?

New 90-day high: US$9.37

Full year 2020 earnings released: EPS US$0.55 (vs US$0.56 in FY 2019)

Rhinebeck Bancorp reports Q4 results

Could The Rhinebeck Bancorp, Inc. (NASDAQ:RBKB) Ownership Structure Tell Us Something Useful?

New 90-day high: US$9.32

Market bids up stock over the past week

Would Shareholders Who Purchased Rhinebeck Bancorp's (NASDAQ:RBKB) Stock Year Be Happy With The Share price Today?

Third quarter 2020 earnings released: EPS US$0.11

New 90-day high: US$7.20

Third quarter earnings released

Rhinebeck Bancorp reports Q3 results

New 90-day low: US$6.36

Insider recently bought US$68k worth of stock

First half earnings released

New 90-day low - US$6.51

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des institutions financières

Découvrir des entreprises saines